Eventide Healthcare & Life Sciences Fund CLASS C SHARES (ETCHX) - Health fund with $1.80 Billion in assets. The fund allocates 26.90% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is CELLDEX THERAPEU at 2.65% of total assets. This is followed by MIRUM PHARMACEUT (3.47%) and VAXCYTE INC (2.69%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| CELLDEX THERAPEU | 2.65% | - | - |
| MIRUM PHARMACEUT | 3.47% | - | - |
| VAXCYTE INC | 2.69% | - | - |
| INSMED INC | 3.78% | - | - |
| AURA BIOSCIENCES | 2.59% | - | - |
| GUARDANT HEALTH | 5.37% | - | - |
| COLLEGIUM PHARMA | 2.85% | - | - |
| AXSOME THERAPEUT | 3.50% | - | - |
| SAREPTA THERAPEU | None | - | - |
| LEXEO THERAPEUTI | None | - | - |
| US BANK MMDA - USBGFS 9 | 3.75% | - | - |
| EVOLENT HEALTH-A | 2.74% | - | - |
| EXACT SCIENCES | 2.58% | - | - |
| CRINETICS PHARMA | 2.52% | - | - |
| VERONA PHAR-ADR | 4.41% | - | - |
| SCHOLAR ROCK HOL | 2.49% | - | - |
| BLUEPRINT MEDICI | 2.93% | - | - |
| CELCUITY INC | 4.00% | - | - |
| ALNYLAM PHARMACE | 3.42% | - | - |
| IRHYTHM TECHNOLO | 2.85% | - | - |
| KYMERA THERAPEUT | 3.22% | - | - |
| BETA BIONICS | 3.19% | - | - |
| BELITE BIO INC | 2.83% | - | - |
| IONIS PHARMACEUT | 2.72% | - | - |
| ABIVAX SA-ADR | 2.94% | - | - |
| APOGEE THERAPEUT | 2.96% | - | - |
| ARGENX SE - ADR | 2.26% | - | - |
| TREVI THERAPEUTI | 2.77% | - | - |
| MBX BIOSCIENCES | 2.70% | - | - |
| CYTOKINETICS INC | 2.69% | - | - |